ANET vs PFE: Which Is the Better Buy?
Side-by-side comparison of Arista Networks, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Arista Networks, Inc. · Technology
$172.86
+82.8% upside to fair value
Grade C
High Quality
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
ANET has more upside to fair value
(+82.8%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ANET |
PFE |
| Current Price |
$172.86 |
$26.91 |
| Fair Value Estimate |
$316.03 |
$35.00 |
| Upside to Fair Value |
+82.8%
|
+30.1%
|
| Market Cap |
$217.7B |
$153.0B |
| Forward P/E |
61.9x
|
9.5x
|
| EV / EBITDA |
54.9x
|
13.8x
|
| Price / Sales |
24.2x
|
2.4x
|
| Price / FCF |
51.2x
|
16.8x
|
| Revenue Growth YoY |
+28.9%
|
-1.6%
|
| Gross Margin |
64.1%
|
70.3%
|
| Operating Margin |
42.8%
|
24.7%
|
| Return on Equity |
31.0%
|
9.0%
|
| Dividend Yield |
0% |
6.4% |
| FCF Yield |
1.95%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Arista Networks is a leading provider of high-speed data center networking hardware and software, specializing in Ethernet switches and cloud networking solutions. The company benefits from strong revenue growth driven by AI and hyperscale cloud demand, with 28.9% revenue growth and 19.3% earnings growth in the most recent quarter. High margins, including a 64.1% gross margin and 42.8% operating …
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
ANET |
PFE |
| Zone Low |
$237.02 |
$25.00 |
| Zone High |
$268.63 |
$29.00 |
| In Buy Zone? |
Yes
|
Yes
|